Literature DB >> 24904094

Worming along in amyloid cardiotoxicity.

Ronglih Liao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24904094      PMCID： PMC4047492          DOI： 10.1182/blood-2014-04-566703

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Review: history of the amyloid fibril.

Authors:  J D Sipe; A S Cohen
Journal:  J Struct Biol       Date:  2000-06       Impact factor: 2.867

Review 2.  Caenorhabditis elegans muscle: a genetic and molecular model for protein interactions in the heart.

Authors:  Guy M Benian; Henry F Epstein
Journal:  Circ Res       Date:  2011-10-14       Impact factor: 17.367

3.  Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL.

Authors:  Giovanni Palladini; Francesca Lavatelli; Paola Russo; Stefano Perlini; Vittorio Perfetti; Tiziana Bosoni; Laura Obici; Arthur R Bradwell; GianVico Melzi D'Eril; Roberto Fogari; Remigio Moratti; Giampaolo Merlini
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

Review 4.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

Review 5.  Amyloidosis: pathogenesis and new therapeutic options.

Authors:  Giampaolo Merlini; David C Seldin; Morie A Gertz
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

6.  Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway.

Authors:  Jianru Shi; Jian Guan; Bingbing Jiang; Daniel A Brenner; Federica Del Monte; Jennifer E Ward; Lawreen H Connors; Douglas B Sawyer; Marc J Semigran; Thomas E Macgillivray; David C Seldin; Rodney Falk; Ronglih Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-11       Impact factor: 11.205

7.  Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts.

Authors:  R Liao; M Jain; P Teller; L H Connors; S Ngoy; M Skinner; R H Falk; C S Apstein
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

8.  Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis.

Authors:  Jennifer Ellis Ward; Ruiyi Ren; Gianluca Toraldo; Pam Soohoo; Jian Guan; Carl O'Hara; Ravi Jasuja; Vickery Trinkaus-Randall; Ronglih Liao; Lawreen H Connors; David C Seldin
Journal:  Blood       Date:  2011-10-12       Impact factor: 22.113

9.  A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis.

Authors:  Luisa Diomede; Paola Rognoni; Francesca Lavatelli; Margherita Romeo; Elena del Favero; Laura Cantù; Elena Ghibaudi; Andrea di Fonzo; Alessandro Corbelli; Fabio Fiordaliso; Giovanni Palladini; Veronica Valentini; Vittorio Perfetti; Mario Salmona; Giampaolo Merlini
Journal:  Blood       Date:  2014-03-24       Impact factor: 22.113

10.  Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.

Authors:  Daniel A Brenner; Mohit Jain; David R Pimentel; Bo Wang; Lawreen H Connors; Martha Skinner; Carl S Apstein; Ronglih Liao
Journal:  Circ Res       Date:  2004-03-25       Impact factor: 17.367
  10 in total
  1 in total

Review 1.  Storage diseases with hypertrophic cardiomyopathy phenotype.

Authors:  Luis Ruiz-Guerrero; Roberto Barriales-Villa
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.